GS
TFFP

Gagnon Securities’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Gagnon Securities’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,503
Closed -$56.9K – 106
2023
Q3 		$56.9K Buy
6,503
+60
+0.9% +$562 0.01% 93
2023
Q2 		$75.7K Sell
6,443
-2,405
-27% -$34.6K 0.02% 95
2023
Q1 		$152K Buy
8,848
+6,357
+255% +$138K 0.03% 104
2022
Q4 		$369K Sell
2,491
-8,902
-78% -$422K 0.08% 73
2022
Q3 		$1.16M Buy
11,393
+19
+0.2% +$2.57K 0.25% 48
2022
Q2 		$1.61M Buy
11,374
+1,253
+12% +$175K 0.34% 47
2022
Q1 		$1.6M Buy
10,121
+22
+0.2% +$3.55K 0.26% 48
2021
Q4 		$2.24M Sell
10,099
-1,190
-11% -$230K 0.34% 42
2021
Q3 		$2.18M Sell
11,289
-7,055
-38% -$1.5M 0.32% 44
2021
Q2 		$4.41M Buy
18,344
+3,225
+21% +$884K 0.63% 40
2021
Q1 		$5.13M Buy
15,119
+5,804
+62% +$2.36M 0.78% 37
2020
Q4 		$3.33M Buy
9,315
+532
+6% +$205K 0.53% 37
2020
Q3 		$4.06M Sell
8,783
-25
-0.3% -$7.06K 0.86% 31
2020
Q2 		$1.27M Buy
+8,808
New +$1.11M 0.31% 45

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Gagnon Securities's TFFP Position: Q4 2023 in Review

Gagnon Securities sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 6,503 shares — an estimated $56.9K sold.

Gagnon Securities first reported a position in TFFP in Q2 2020 and held it in 14 quarters. The position peaked at $5.13M in Q1 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Gagnon Securities reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Gagnon Securities sold 6,503 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $56.9K.
  • Gagnon Securities first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Gagnon Securities's TFF Pharmaceuticals, Inc. Common Stock position peaked at $5.13M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Gagnon Securities's 13F filing for Q4 2023, filed 14 Feb 2024.